Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2026-01-03 @ 3:20 AM
Study NCT ID:
NCT03240393
Status:
WITHDRAWN
Last Update Posted:
2018-07-26
First Post:
2017-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-10-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-10-26
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-26
First Submit QC Date:
None
Study First Post Date:
2017-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-24
Last Update Post Date:
2018-07-26
Last Update Post Date Type:
ACTUAL